Publications by authors named "Cornelia Dechant"

Claim this Profile
F
Fair Funding Decisions: Consistency of the Time Horizons Used in the Calculation of Quality-Adjusted Life Years for Therapies for Very Rare Diseases by the National Institute for Health and Care Excellence in England.
Jasmin Barman-Aksözen, Nicole Hentschel, Mårten Pettersson, Eva Schupp, Francesca Granata, Cornelia Dechant

Int J Environ Res Public Health· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dersimelagon in Erythropoietic Protoporphyrias.
Francesca Granata, Cornelia Dechant, Rocco Falchetto

N Engl J Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-Adjusted Life Years in Erythropoietic Protoporphyria and Other Rare Diseases: A Patient-Initiated EQ-5D Feasibility Study.
Jasmin Barman-Aksözen, Anna-Elisabeth Minder, Francesca Granata, Mårten Pettersson, Cornelia Dechant

Int J Environ Res Public Health· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure changes after renal denervation are more pronounced in women and nondiabetic patients: findings from the Austrian Transcatheter Renal Denervation Registry.
David Zweiker, Thomas Lambert, Clemens Steinwender, Thomas Weber, Markus Suppan, Cornelia Dechant

J Hypertens· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Renal Denervation Documented in the Austrian National Multicentre Renal Denervation Registry.
David Zweiker, Thomas Lambert, Clemens Steinwender, Thomas Weber, Markus Suppan, Cornelia Dechant

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrocardiogram changes and wall motion abnormalities in the acute phase of Tako-Tsubo syndrome.
Valerie Weihs, Daniela Szücs, Barbara Fellner, Bernd Eber, Wolfgang Weihs, Cornelia Dechant

Eur Heart J Acute Cardiovasc Care· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The net clinical benefit of personalized antiplatelet therapy in patients undergoing percutaneous coronary intervention.
Jolanta M Siller-Matula, Carina Gruber, Marcel Francesconi, Cornelia Dechant, Bernd Jilma

Clin Sci (Lond)· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.
Günter Christ, Jolanta M Siller-Matula, Marcel Francesconi, Cornelia Dechant, Katharina Grohs

BMJ Open· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study.
Jolanta M Siller-Matula, Marcel Francesconi, Cornelia Dechant, Bernd Jilma, Gerald Maurer

Int J Cardiol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress-induced cardiomyopathy (Tako-Tsubo syndrome) in Austria.
Valerie Weihs, Daniela Szücs, Barbara Fellner, Bernd Eber, Wolfgang Weihs, Cornelia Dechant

Eur Heart J Acute Cardiovasc Care· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Reversible Heart Failure Caused by Coronary Vasoconstriction due to Continuous 5-Fluorouracil Combination Chemotherapy.
Cornelia Dechant, Martina Baur, Rudolf Böck, Martin Czejka, Andrea Podczeck-Schweighofer

Case Rep Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis